COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
Ontology highlight
ABSTRACT: With the global spread of SARS-CoV-2, millions of people have been affected leading to the declaration of coronavirus disease 2019 (COVID-19) as a pandemic by the WHO. Several studies have linked the severity of COVID-19 cases and increased fatality in patients with obesity and other comorbid conditions such as diabetes, cardiovascular diseases, hypertension, and kidney disease. Obesity, a metabolically deranged condition, establishes a low-grade chronic inflammation in the body, which affects different organs and promotes the development of several other diseases. The ways in which SARS-CoV-2 infection aggravates the already overloaded body organs with inflammation or vice versa has perplexed the researchers. As a result, there is an intensified search for the clear-cut mechanism to under
SUBMITTER: Sharma JR
PROVIDER: S-EPMC7816622 | biostudies-literature | 2021 Mar-Apr
REPOSITORIES: biostudies-literature
ACCESS DATA